PlainPharmaWatch

CMS Open Payments · Program Year 2024

Trillium Therapeutics USA, LLC

Trillium Therapeutics USA, LLC reported $1,348,775.39 in payments to 0 physicians and teaching hospitals across 403 transactions.

See the rankings → How this is sourced
$1.3M
Total payments
403
Transactions
0
Recipients
#546
of 1,925 companies

Trillium Therapeutics USA, LLC reported $1,348,775.39 in payments to 0 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #546 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $0.00 per recipient across 0 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Trillium Therapeutics USA, LLC posts above-median payment volume among 1,925 companies reporting payments in CMS Open Payments PY2024.

#546
of 1,925 companies
0.0%
of all US industry payments
0
payment categories

How Trillium Therapeutics USA, LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Trillium Therapeutics USA, LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,348,775 Top 28% higher than 72% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Trillium Therapeutics USA, LLC

Rank #546 of 1,925 companies in CMS Open Payments for 2024 belongs to Trillium Therapeutics USA, LLC, which reported $1,348,775.39 across 403 transactions to 0 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $3.3K per transaction and $0.00 per recipient.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Payment Size Analysis

Average transaction size: $3.3K. Average per recipient: $0.00.

Total Amount

$1,348,775.39

Avg per Transaction

$3.3K

Avg per Recipient

$0.00

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Trillium Therapeutics USA, LLC Share

0.0%

#546 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Trillium Therapeutics USA, LLC

Vilex LLC

$1.3M 1,040 recipients

Biofrontera Bioscience GmbH

$1.3M 0 recipients

Vericel Corporation

$1.3M 3,314 recipients

Telix Pharmaceuticals

$1.3M 2,920 recipients

Leadiant Biosciences, Inc.

$1.3M 65 recipients

Surmodics, Inc.

$1.3M 2,433 recipients

Frequently Asked Questions

How much did Trillium Therapeutics USA, LLC pay to physicians and hospitals in 2024? ▾
Trillium Therapeutics USA, LLC made $1,348,775.39 in payments to physicians and hospitals in Program Year 2024, across 403 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Trillium Therapeutics USA, LLC? ▾
0 physicians and teaching hospitals received payments from Trillium Therapeutics USA, LLC in 2024, averaging $0.00 per recipient.
What types of payments did Trillium Therapeutics USA, LLC make? ▾
0 categories of general payment make up Trillium Therapeutics USA, LLC's reported activity, including consulting, meals, travel, and similar types.
How does Trillium Therapeutics USA, LLC rank among pharmaceutical companies? ▾
By total payment amount, Trillium Therapeutics USA, LLC sits at #546 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Trillium Therapeutics USA, LLC? ▾
The average transaction from Trillium Therapeutics USA, LLC was $3.3K in 2024. The company made 403 total transactions to 0 recipients.
Where does the payment data for Trillium Therapeutics USA, LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Trillium Therapeutics USA, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.